Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|September 5, 2009
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapyRhys D Clyburn, Penny Reid, Catherine A Evans, et al.Anti-Cancer Drugs|August 13, 2005
Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitroJulia K L Woodward, Helen L Neville-Webbe, Robert E Coleman, et al.Alternatives to Laboratory Animals : ATLA|January 13, 2016
SEARCHBreast Workshop Proceedings: 3D Modelling of Breast CancerBethny Morrissey, Karen Blyth, Phil Carter, et al.Breast Cancer Research and Treatment|April 17, 2016
SEARCHBreast: a new resource to locate and share surplus archival material from breast cancer animal models to help address the 3RsKaren Blyth, Phil Carter, Bethny Morrissey, et al.Plos Biology|January 13, 2017
The Sharing Experimental Animal Resources, Coordinating Holdings (SEARCH) Framework: Encouraging Reduction, Replacement, and Refinement in Animal ResearchBethny Morrissey, Karen Blyth, Phil Carter, et al.The Prostate|March 26, 2004
Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancerColby L Eaton, Jason M Wells, Ingunn Holen, et al.NPJ Breast Cancer|July 20, 2017
Introducing SEARCHBreast: a virtual resource to facilitate sharing of surplus animal material developed for breast cancer researchBethny Morrissey, Ingunn Holen, Claude Chelala, et al.Nature Clinical Practice. Oncology|June 8, 2006
Mechanisms of disease: Preclinical reports of antineoplastic synergistic action of bisphosphonatesDaniele Santini, Michele Caraglia, Bruno Vincenzi, et al.Journal of the National Cancer Institute|August 13, 2008
Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancerPenelope D Ottewell, Hannu Mönkkönen, Mark Jones, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 7, 2019
Bone marrow osteoprogenitors are depleted whereas osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acidRussell Hughes, Xinyue Chen, Keith D Hunter, et al.Pageof 9